As a result, determining patients’ genotypes may be able to reduce the extent of cardiovascular risk and mortality trends in the CKD population, as the ACE I/D polymorphism described in this study provides a possible tool for patient prevention and early intervention treatment. The gene discussed is ACE; the disease is chronic kidney disease.